Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Sees Large Growth in Short Interest

Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) was the recipient of a large increase in short interest in February. As of February 28th, there was short interest totalling 103,300 shares, an increase of 225.9% from the February 13th total of 31,700 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 487,700 shares, the short-interest ratio is presently 0.2 days.

Analyst Upgrades and Downgrades

Several research firms recently commented on RBGLY. HSBC raised Reckitt Benckiser Group from a "hold" rating to a "buy" rating in a research note on Wednesday, December 11th. Barclays downgraded shares of Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a research note on Tuesday, February 4th. Hsbc Global Res raised shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, December 11th. Finally, Royal Bank of Canada reissued an "outperform" rating on shares of Reckitt Benckiser Group in a research note on Friday, March 7th. Three analysts have rated the stock with a hold rating, two have assigned a buy rating and three have issued a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Buy".

Reckitt Benckiser Group Price Performance

RBGLY traded down $0.23 during mid-day trading on Thursday, hitting $13.44. 776,308 shares of the stock were exchanged, compared to its average volume of 312,964. The company has a debt-to-equity ratio of 0.97, a current ratio of 0.69 and a quick ratio of 0.47. The firm's fifty day moving average is $12.92 and its two-hundred day moving average is $12.45. Reckitt Benckiser Group has a 1-year low of $10.24 and a 1-year high of $14.10.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Remove Ads